教員業績データベース |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis? |
掲載誌名 | 正式名:Targeted oncology ISSNコード:1776260X/17762596 |
掲載区分 | 国外 |
巻・号・頁 | 18(2),pp.221-233 |
著者・共著者 | Margherita Rimini, Mara Persano, Tada Toshifumi, Suda Goki, Shimose Shigeo, Kudo Masatoshi, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Francesca Salani, Sara Lonardi, Fabio Piscaglia, Kumada Takashi, Sakamoto Naoya, Iwamoto Hideki, Aoki Tomoko, Hong Jae Chon, Vera Himmelsbach, Marta Schirripa, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Hiraoka Atsushi, Iijima Hiroko…Andrea Casadei-Gardini |
発行年月 | 2023/03 |